These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 33769386

  • 21. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds.
    Shields CL, Bianciotto CG, Jabbour P, Ramasubramanian A, Lally SE, Griffin GC, Rosenwasser R, Shields JA.
    Arch Ophthalmol; 2011 Nov; 129(11):1399-406. PubMed ID: 21670328
    [Abstract] [Full Text] [Related]

  • 22. Periocular topotecan for vitreous seeds in retinoblastoma.
    Sthapit PR, Rao R, Honavar SG.
    Indian J Ophthalmol; 2018 Dec; 66(12):1833-1838. PubMed ID: 30451190
    [Abstract] [Full Text] [Related]

  • 23. Management and outcome of retinoblastoma with vitreous seeds.
    Manjandavida FP, Honavar SG, Reddy VA, Khanna R.
    Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
    [Abstract] [Full Text] [Related]

  • 24. A Multicenter, International Collaborative Study for American Joint Committee on Cancer Staging of Retinoblastoma: Part I: Metastasis-Associated Mortality.
    Tomar AS, Finger PT, Gallie B, Mallipatna A, Kivelä TT, Zhang C, Zhao J, Wilson MW, Kim J, Khetan V, Ganesan S, Yarovoy A, Yarovaya V, Kotova E, Yousef YA, Nummi K, Ushakova TL, Yugay OV, Polyakov VG, Ramirez-Ortiz MA, Esparza-Aguiar E, Chantada G, Schaiquevich P, Fandino A, Yam JC, Lau WW, Lam CP, Sharwood P, Moorthy S, Long QB, Essuman VA, Renner LA, Català J, Correa-Llano G, American Joint Committee on Cancer Ophthalmic Oncology Task Force.
    Ophthalmology; 2020 Dec; 127(12):1719-1732. PubMed ID: 32512116
    [Abstract] [Full Text] [Related]

  • 25. Optical Coherence Tomography-Guided Decisions in Retinoblastoma Management.
    Soliman SE, VandenHoven C, MacKeen LD, Héon E, Gallie BL.
    Ophthalmology; 2017 Jun; 124(6):859-872. PubMed ID: 28318638
    [Abstract] [Full Text] [Related]

  • 26. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
    Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Singh A, Friedman DL, Naduvilath TJ.
    Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
    [Abstract] [Full Text] [Related]

  • 27. Selective Ophthalmic Artery Chemotherapy with Melphalan in the Management of Unilateral Retinoblastoma: A Prospective Study.
    Lumbroso-Le Rouic L, Blanc R, Saint Martin C, Savignoni A, Brisse HJ, Pierrat N, Lévy-Gabriel C, Matet A, Doz F, Aerts I, Cassoux N.
    Ophthalmol Retina; 2021 Aug; 5(8):e30-e37. PubMed ID: 34000459
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Enucleated globes with advanced retinoblastoma: correlation of histopathological features and reclassification of tumors according to the 8th edition of the American Joint Committee on Cancer (AJCC).
    Alkatan HM, AlQahtani FS, Maktabi AM.
    Int Ophthalmol; 2020 Jul; 40(7):1739-1747. PubMed ID: 32193778
    [Abstract] [Full Text] [Related]

  • 31. Retinoblastoma in Asia: Clinical Presentation and Treatment Outcomes in 2112 Patients from 33 Countries.
    Kaliki S, Vempuluru VS, Mohamed A, Al-Jadiry MF, Bowman R, Chawla B, Hamid SA, Ji X, Kapelushnik N, Kebudi R, Sthapit PR, Rojanaporn D, Sitorus RS, Yousef YA, Fabian ID, Global Retinoblastoma Study Group.
    Ophthalmology; 2024 Apr; 131(4):468-477. PubMed ID: 37839559
    [Abstract] [Full Text] [Related]

  • 32. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
    Shields CL, Honavar SG, Shields JA, Demirci H, Meadows AT, Naduvilath TJ.
    Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
    [Abstract] [Full Text] [Related]

  • 33. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.
    Shields CL, Manjandavida FP, Lally SE, Pieretti G, Arepalli SA, Caywood EH, Jabbour P, Shields JA.
    Ophthalmology; 2014 Jul; 121(7):1453-60. PubMed ID: 24656794
    [Abstract] [Full Text] [Related]

  • 34. Ocular preservation in patients with bilateral retinoblastoma before chemotherapy in situ era: A report from a Mexican Retinoblastoma Reference Hospital.
    Del Carmen Bernal-Díaz Z, Murillo-Maldonado MA, Pérez-Villanueva H, Reyes-López A, Ramírez-Ortiz MA.
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28625. PubMed ID: 32743978
    [Abstract] [Full Text] [Related]

  • 35. Clinical presentation and outcome of retinoblastoma based on age at presentation: a review of 1450 children.
    Kaliki S, Maniar A, Patel A, Palkonda VAR, Mohamed A.
    Int Ophthalmol; 2020 Jan; 40(1):99-107. PubMed ID: 31444587
    [Abstract] [Full Text] [Related]

  • 36. Global Retinoblastoma Treatment Outcomes: Association with National Income Level.
    Tomar AS, Finger PT, Gallie B, Kivelä TT, Mallipatna A, Zhang C, Zhao J, Wilson MW, Brenna RC, Burges M, Kim J, Khetan V, Ganesan S, Yarovoy A, Yarovaya V, Kotova E, Yousef YA, Nummi K, Ushakova TL, Yugay OV, Polyakov VG, Ramirez-Ortiz MA, Esparza-Aguiar E, Chantada G, Schaiquevich P, Fandino A, Yam JC, Lau WW, Lam CP, Sharwood P, Moorthy S, Long QB, Essuman VA, Renner LA, Semenova E, Català J, Correa-Llano G, Carreras E, American Joint Committee on Cancer Ophthalmic Oncology Task Force.
    Ophthalmology; 2021 May; 128(5):740-753. PubMed ID: 33007338
    [Abstract] [Full Text] [Related]

  • 37. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
    Shields CL, Mashayekhi A, Cater J, Shelil A, Ness S, Meadows AT, Shields JA.
    Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
    [Abstract] [Full Text] [Related]

  • 38. Thermotherapy for retinoblastoma.
    Shields CL, Santos MC, Diniz W, Gündüz K, Mercado G, Cater JR, Shields JA.
    Arch Ophthalmol; 1999 Jul; 117(7):885-93. PubMed ID: 10408452
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.